- Home
- » Tags
- » Fosphenytoin
Top View
- Review of Existing Classification Efforts
- 2021 Equine Prohibited Substances List
- Material Safety Data Sheet
- Pharmacology of Antiepileptic Drugs
- Reseptregisteret 2014–2018 the Norwegian Prescription Database 2014–2018
- Rev Cerebyx Final Safety Review 2019
- Drug Utilization Review Board
- The Role of Sodium Channels in Disease
- Division of Vital Statistics, Mortality Data Table Page 1 of 147
- Pharmacologic Management of Neonatal Seizures Brandy Zeller, Pharmd Jeanne Giebe, MSN, NNP-BC, RN
- Mgh Status Epilepticus Treatment Protocol
- Pearls and Pitfalls of Introducing Ketogenic Diet in Adult Status Epilepticus: a Practical Guide for the Intensivist
- E3. Antiepileptic Drugs.Pdf
- MOCD Excessive Dosage Guidelines 11.30.2020
- Medication Treatment Pathway- Convulsive Or Non-Convulsive Status Epilepticus Applicability- Any Adult Patient (>40 Kg) With: 1
- Levetiracetam Versus Fosphenytoin As a Second-Line Treatment After Diazepam for Status Epilepticus: Study Protocol for a Multice
- NOTE: to Chan Image O Slide, Se the Pictu Delete It Click the Pictures The
- Drug Consumption Databases in Europe
- Pharmacokinetic Characteristics of Antiepileptic Drugs (Aeds)
- Summary of Product Characteristics
- Tegretol Data Sheet
- Download Chargemaster
- Acute Seizure Management Guideline Children >1 Month Old Use As Recommendation, Not to Replace Clinical Judgment
- Episode 90 – Low and Slow Poisoning Toxicological Causes
- The Association of Patient Weight and Dose of Fosphenytoin, Levetiracetam, and Valproic Acid with Treatment Success in Status Epilepticus
- CDM WEB-Aug-W
- Advances in Current Medication and New Therapeutic Approaches in Epilepsy
- NDA 20450 Suppl 003, Clinical Review
- Fosphenytoin Sodium Injection USP 75 Mg/Ml 2 Ml Vial
- Hazardous Drug List PHARMACY Handling Categories Category A1 (Low Risk): Primarily Oral Solids That Are Not Anti-Neoplastics
- CEREBYX® (Fosphenytoin Sodium Injection)
- [2016]. NIOSH List of Antineoplastic and Other Hazardous Drugs in Healthcare Settings, 2016
- Neuropharmacology III Anticonvulsants
- PHENYTOIN and FOSPHENYTOIN Michael E
- Drugs Associated with Qt Interval Prolongation2–65
- Does the Benefit of Therapeutic Hypothermia in Refractory Status Epilepticus Depend on Seizure Etiology? Jessica R
- Risk of Seizures Associated with Ranolazine (Ranexa)
- Interactions of Oral Contraceptives and Seizure Medications to Drugs
- Antiepileptic Drug Utilization: Need of Sex-Specific Information and Decision Support
- Topiramate for Seizures in Preterm Infants and the Development of Necrotizing Enterocolitis
- CEREBYX® (Fosphenytoin Sodium Injection) Is a Prodrug Intended for Parenteral Administration; Its Active Metabolite Is Phenytoin
- New Methods Used in Pharmacokinetics and Therapeutic Monitoring of the First and Newer Generations of Antiepileptic Drugs (Aeds)
- Cedars-Sinai Chargemaster 2021
- Fosphenytoin and Phenytoin – Adult/Pediatric – Inpatient Clinical Practice Guideline
- Resolution Ap (2000) 1
- New Anticonvulsant Agents
- Fosphenytoin Is Completely Converted to Phenytoin Following IV Administration, with a Fosphenytoin Should Be Discontinued If a Skin Rash Appears
- Download Product Insert (PDF)
- Status Epilepticus Algorithm 1